VERICEL CORPORATION Receivables, Net, Current
VERICEL CORPORATION (VCEL) had Receivables, Net, Current of $28.00 thousand as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2013-03-18
- 2012-12-31: Receivables, Net, Current $28.00K.
- 2012-09-30: Receivables, Net, Current $9.00K.
- 2012-06-30: Receivables, Net, Current $9.00K.
- 2012-03-31: Receivables, Net, Current $11.00K.
| Period end | Receivables, Net, Current |
|---|---|
| 2012-12-31 | $28.00K 10-K · filed 2013-03-18 |
| 2012-09-30 | $9.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $9.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $11.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $9.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $9.00K 10-Q · filed 2011-11-08 |
| 2010-12-31 | $25.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |